UNSPSC 51413500: Vasodilator pyridines

Vasodilator drugs made from compounds with a six membered aromatic ring containing nitrogen.

UNSPSC 51413500 Vasodilator pyridines is a Class code encompassing prescription and over-the-counter medications acquired by state and local public bodies for emergency medical services, pharmacy benefit programs, and institutional health care operations. State and local procurement under this code spans emergency medications supplied to fire and rescue services, generic pharmaceuticals distributed through multi-state cooperative purchasing networks, and direct-to-manufacturer pharmacy initiatives operated by state health agencies. Issuing bodies include municipal purchasing departments (city fire rescue operations), state health and human services commissions managing pharmacy benefit programs, and cooperative purchasing alliances administering multi-jurisdictional pharmaceutical procurement. The scope includes sealed competitive bidding for specific medication line items with firm pricing and delivery requirements, cooperative RFPs establishing framework agreements with multiple authorized wholesalers, and exploratory RFIs gathering vendor capabilities for emerging procurement models such as direct contracting outside traditional pharmacy benefit manager and group purchasing organization channels.

Recent activity spans Florida, Texas, and Minnesota. The City of Tampa's Purchasing Department issued IFB 26P00188 for Advanced Life Support Medications (response due April 8, 2026) requiring sealed bids for four specific medications—Labetalol, Epinephrine, Adenosine, and Diltiazem—for Tampa Fire Rescue with an estimated contract value of $40,000 and a five-percent bid discount available for Small Local Business Enterprise participation. The Minnesota Department of Administration's Office of State Procurement, administering the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), issued RFP S1070000015802 for generic multi-source pharmaceuticals and OTC products (response due March 26, 2026) establishing two-year framework agreements with participating state and local government facilities including Oregon, requiring vendors to maintain relationships with three authorized wholesalers and comply with cGMP and Drug Supply Chain Security Act certification. The Texas Health and Human Services Commission issued RFI HHS0017013 (response due April 3, 2026) to solicit vendor information regarding direct-to-manufacturer prescription programs designed to establish contracts with self-insured employee health plans and state agencies outside existing PBM and GPO channels, signaling emerging state procurement interest in alternative pharmacy benefit delivery models.